Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

No CEO, no leadership, no clear path, and a recently FAILED clinical trial. This simply states that as of right now, they don't know where they are going with the company. You're right in that they are two separate companies working on two separate timelines. Unfortunately this will likely head back to 5-8 cents because there is no clearly defined plan of attack. Even those the technology is similar, without a plan, and someone to actually direct it, we know that there is nothing to sustain a SP increase.

But like Spliffy has stated, it's worth keeping an eye on, but VERY risky at this point. Maybe Cannabix management knew that if they had two companies doing well that it would create an issue legally, so they took the one succeeding an went with it.

And lastly... why did this stock just shoot above 20 cents Canadian for absolutely zero reason...? I mean I am not complaining... but I don't understand.